290 related articles for article (PubMed ID: 34253291)
1. Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world.
Toor J; Echeverria-Londono S; Li X; Abbas K; Carter ED; Clapham HE; Clark A; de Villiers MJ; Eilertson K; Ferrari M; Gamkrelidze I; Hallett TB; Hinsley WR; Hogan D; Huber JH; Jackson ML; Jean K; Jit M; Karachaliou A; Klepac P; Kraay A; Lessler J; Li X; Lopman BA; Mengistu T; Metcalf CJE; Moore SM; Nayagam S; Papadopoulos T; Perkins TA; Portnoy A; Razavi H; Razavi-Shearer D; Resch S; Sanderson C; Sweet S; Tam Y; Tanvir H; Tran Minh Q; Trotter CL; Truelove SA; Vynnycky E; Walker N; Winter A; Woodruff K; Ferguson NM; Gaythorpe KA
Elife; 2021 Jul; 10():. PubMed ID: 34253291
[TBL] [Abstract][Full Text] [Related]
2. Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study.
Hartner AM; Li X; Echeverria-Londono S; Roth J; Abbas K; Auzenbergs M; de Villiers MJ; Ferrari MJ; Fraser K; Fu H; Hallett T; Hinsley W; Jit M; Karachaliou A; Moore SM; Nayagam S; Papadopoulos T; Perkins TA; Portnoy A; Minh QT; Vynnycky E; Winter AK; Burrows H; Chen C; Clapham HE; Deshpande A; Hauryski S; Huber J; Jean K; Kim C; Kim JH; Koh J; Lopman BA; Pitzer VE; Tam Y; Lambach P; Sim SY; Woodruff K; Ferguson NM; Trotter CL; Gaythorpe KAM
Lancet Glob Health; 2024 Apr; 12(4):e563-e571. PubMed ID: 38485425
[TBL] [Abstract][Full Text] [Related]
3. Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study.
Li X; Mukandavire C; Cucunubá ZM; Echeverria Londono S; Abbas K; Clapham HE; Jit M; Johnson HL; Papadopoulos T; Vynnycky E; Brisson M; Carter ED; Clark A; de Villiers MJ; Eilertson K; Ferrari MJ; Gamkrelidze I; Gaythorpe KAM; Grassly NC; Hallett TB; Hinsley W; Jackson ML; Jean K; Karachaliou A; Klepac P; Lessler J; Li X; Moore SM; Nayagam S; Nguyen DM; Razavi H; Razavi-Shearer D; Resch S; Sanderson C; Sweet S; Sy S; Tam Y; Tanvir H; Tran QM; Trotter CL; Truelove S; van Zandvoort K; Verguet S; Walker N; Winter A; Woodruff K; Ferguson NM; Garske T;
Lancet; 2021 Jan; 397(10272):398-408. PubMed ID: 33516338
[TBL] [Abstract][Full Text] [Related]
4. The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance.
Lee LA; Franzel L; Atwell J; Datta SD; Friberg IK; Goldie SJ; Reef SE; Schwalbe N; Simons E; Strebel PM; Sweet S; Suraratdecha C; Tam Y; Vynnycky E; Walker N; Walker DG; Hansen PM
Vaccine; 2013 Apr; 31 Suppl 2():B61-72. PubMed ID: 23598494
[TBL] [Abstract][Full Text] [Related]
5. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study.
Watson OJ; Barnsley G; Toor J; Hogan AB; Winskill P; Ghani AC
Lancet Infect Dis; 2022 Sep; 22(9):1293-1302. PubMed ID: 35753318
[TBL] [Abstract][Full Text] [Related]
6. Modeling the impact of vaccination for the immunization Agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030.
Carter A; Msemburi W; Sim SY; Gaythorpe KAM; Lambach P; Lindstrand A; Hutubessy R
Vaccine; 2023 Aug; ():. PubMed ID: 37537094
[TBL] [Abstract][Full Text] [Related]
7. Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection.
Abbas K; Procter SR; van Zandvoort K; Clark A; Funk S; Mengistu T; Hogan D; Dansereau E; Jit M; Flasche S;
Lancet Glob Health; 2020 Oct; 8(10):e1264-e1272. PubMed ID: 32687792
[TBL] [Abstract][Full Text] [Related]
8. An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients.
Gonçalves BP; Hall M; Jassat W; Balan V; Murthy S; Kartsonaki C; Semple MG; Rojek A; Baruch J; Reyes LF; Dasgupta A; Dunning J; Citarella BW; Pritchard M; Martín-Quiros A; Sili U; Baillie JK; Aryal D; Arabi Y; Rashan A; Angheben A; Caoili J; Carrier FM; Harrison EM; Gómez-Junyent J; Figueiredo-Mello C; Douglas JJ; Mat Nor MB; Chow YP; Wong XC; Bertagnolio S; Thwin SS; Streinu-Cercel A; Salazar L; Rishu A; Rangappa R; Ong DSY; Hashmi M; Carson G; Diaz J; Fowler R; Kraemer MUG; Wils EJ; Horby P; Merson L; Olliaro PL;
Elife; 2022 Oct; 11():. PubMed ID: 36197074
[TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.
Gaythorpe KA; Abbas K; Huber J; Karachaliou A; Thakkar N; Woodruff K; Li X; Echeverria-Londono S; ; Ferrari M; Jackson ML; McCarthy K; Perkins TA; Trotter C; Jit M
Elife; 2021 Jun; 10():. PubMed ID: 34165077
[TBL] [Abstract][Full Text] [Related]
10. The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients.
Alexander JL; Mullish BH; Danckert NP; Liu Z; Olbei ML; Saifuddin A; Torkizadeh M; Ibraheim H; Blanco JM; Roberts LA; Bewshea CM; Nice R; Lin S; Prabhudev H; Sands C; Horneffer-van der Sluis V; Lewis M; Sebastian S; Lees CW; Teare JP; Hart A; Goodhand JR; Kennedy NA; Korcsmaros T; Marchesi JR; Ahmad T; Powell N
EBioMedicine; 2023 Feb; 88():104430. PubMed ID: 36634565
[TBL] [Abstract][Full Text] [Related]
11. The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models.
Baral R; Li X; Willem L; Antillon M; Vilajeliu A; Jit M; Beutels P; Pecenka C
Vaccine; 2020 Jul; 38(33):5139-5147. PubMed ID: 32586761
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study.
Winter AK; Lambert B; Klein D; Klepac P; Papadopoulos T; Truelove S; Burgess C; Santos H; Knapp JK; Reef SE; Kayembe LK; Shendale S; Kretsinger K; Lessler J; Vynnycky E; McCarthy K; Ferrari M; Jit M
Lancet Glob Health; 2022 Oct; 10(10):e1412-e1422. PubMed ID: 36113527
[TBL] [Abstract][Full Text] [Related]
13. Shaping markets to benefit global health - A 15-year history and lessons learned from the pentavalent vaccine market.
Malhame M; Baker E; Gandhi G; Jones A; Kalpaxis P; Iqbal R; Momeni Y; Nguyen A
Vaccine X; 2019 Aug; 2():100033. PubMed ID: 31384748
[TBL] [Abstract][Full Text] [Related]
14. Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries.
Marijam A; Schuerman L; Izurieta P; Pereira P; Van Oorschot D; Mehta S; Ota MO; Standaert B
Hum Vaccin Immunother; 2022 Dec; 18(7):2135916. PubMed ID: 36507685
[TBL] [Abstract][Full Text] [Related]
15. Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study.
Abbas KM; van Zandvoort K; Brisson M; Jit M
Lancet Glob Health; 2020 Apr; 8(4):e536-e544. PubMed ID: 32105613
[TBL] [Abstract][Full Text] [Related]
16. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Antimicrobial Resistance Collaborators
Lancet; 2022 Dec; 400(10369):2221-2248. PubMed ID: 36423648
[TBL] [Abstract][Full Text] [Related]
17. Predictive performance of multi-model ensemble forecasts of COVID-19 across European nations.
Sherratt K; Gruson H; Grah R; Johnson H; Niehus R; Prasse B; Sandmann F; Deuschel J; Wolffram D; Abbott S; Ullrich A; Gibson G; Ray EL; Reich NG; Sheldon D; Wang Y; Wattanachit N; Wang L; Trnka J; Obozinski G; Sun T; Thanou D; Pottier L; Krymova E; Meinke JH; Barbarossa MV; Leithauser N; Mohring J; Schneider J; Wlazlo J; Fuhrmann J; Lange B; Rodiah I; Baccam P; Gurung H; Stage S; Suchoski B; Budzinski J; Walraven R; Villanueva I; Tucek V; Smid M; Zajicek M; Perez Alvarez C; Reina B; Bosse NI; Meakin SR; Castro L; Fairchild G; Michaud I; Osthus D; Alaimo Di Loro P; Maruotti A; Eclerova V; Kraus A; Kraus D; Pribylova L; Dimitris B; Li ML; Saksham S; Dehning J; Mohr S; Priesemann V; Redlarski G; Bejar B; Ardenghi G; Parolini N; Ziarelli G; Bock W; Heyder S; Hotz T; Singh DE; Guzman-Merino M; Aznarte JL; Morina D; Alonso S; Alvarez E; Lopez D; Prats C; Burgard JP; Rodloff A; Zimmermann T; Kuhlmann A; Zibert J; Pennoni F; Divino F; Catala M; Lovison G; Giudici P; Tarantino B; Bartolucci F; Jona Lasinio G; Mingione M; Farcomeni A; Srivastava A; Montero-Manso P; Adiga A; Hurt B; Lewis B; Marathe M; Porebski P; Venkatramanan S; Bartczuk RP; Dreger F; Gambin A; Gogolewski K; Gruziel-Slomka M; Krupa B; Moszyński A; Niedzielewski K; Nowosielski J; Radwan M; Rakowski F; Semeniuk M; Szczurek E; Zielinski J; Kisielewski J; Pabjan B; Holger K; Kheifetz Y; Scholz M; Przemyslaw B; Bodych M; Filinski M; Idzikowski R; Krueger T; Ozanski T; Bracher J; Funk S
Elife; 2023 Apr; 12():. PubMed ID: 37083521
[TBL] [Abstract][Full Text] [Related]
18. Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020.
Ozawa S; Clark S; Portnoy A; Grewal S; Stack ML; Sinha A; Mirelman A; Franklin H; Friberg IK; Tam Y; Walker N; Clark A; Ferrari M; Suraratdecha C; Sweet S; Goldie SJ; Garske T; Li M; Hansen PM; Johnson HL; Walker D
Bull World Health Organ; 2017 Sep; 95(9):629-638. PubMed ID: 28867843
[TBL] [Abstract][Full Text] [Related]
19. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data.
Brueggemann AB; Jansen van Rensburg MJ; Shaw D; McCarthy ND; Jolley KA; Maiden MCJ; van der Linden MPG; Amin-Chowdhury Z; Bennett DE; Borrow R; Brandileone MC; Broughton K; Campbell R; Cao B; Casanova C; Choi EH; Chu YW; Clark SA; Claus H; Coelho J; Corcoran M; Cottrell S; Cunney RJ; Dalby T; Davies H; de Gouveia L; Deghmane AE; Demczuk W; Desmet S; Drew RJ; du Plessis M; Erlendsdottir H; Fry NK; Fuursted K; Gray SJ; Henriques-Normark B; Hale T; Hilty M; Hoffmann S; Humphreys H; Ip M; Jacobsson S; Johnston J; Kozakova J; Kristinsson KG; Krizova P; Kuch A; Ladhani SN; Lâm TT; Lebedova V; Lindholm L; Litt DJ; Martin I; Martiny D; Mattheus W; McElligott M; Meehan M; Meiring S; Mölling P; Morfeldt E; Morgan J; Mulhall RM; Muñoz-Almagro C; Murdoch DR; Murphy J; Musilek M; Mzabi A; Perez-Argüello A; Perrin M; Perry M; Redin A; Roberts R; Roberts M; Rokney A; Ron M; Scott KJ; Sheppard CL; Siira L; Skoczyńska A; Sloan M; Slotved HC; Smith AJ; Song JY; Taha MK; Toropainen M; Tsang D; Vainio A; van Sorge NM; Varon E; Vlach J; Vogel U; Vohrnova S; von Gottberg A; Zanella RC; Zhou F
Lancet Digit Health; 2021 Jun; 3(6):e360-e370. PubMed ID: 34045002
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
